CorMedix (CRMD) Gross Profit (2016 - 2025)
Historic Gross Profit for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to $93.1 million.
- CorMedix's Gross Profit rose 76429.76% to $93.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.5 million, marking a year-over-year increase of 183133.16%. This contributed to the annual value of $40.3 million for FY2024, which is N/A changed from last year.
- CorMedix's Gross Profit amounted to $93.1 million in Q3 2025, which was up 76429.76% from $37.9 million recorded in Q2 2025.
- In the past 5 years, CorMedix's Gross Profit registered a high of $93.1 million during Q3 2025, and its lowest value of -$818539.0 during Q1 2024.
- Over the past 4 years, CorMedix's median Gross Profit value was $26922.0 (recorded in 2021), while the average stood at $13.9 million.
- Per our database at Business Quant, CorMedix's Gross Profit crashed by 12747.17% in 2021 and then skyrocketed by 1268329.35% in 2025.
- Quarter analysis of 4 years shows CorMedix's Gross Profit stood at $8390.0 in 2021, then surged by 249.18% to $29296.0 in 2022, then skyrocketed by 102420.4% to $30.0 million in 2024, then surged by 209.91% to $93.1 million in 2025.
- Its last three reported values are $93.1 million in Q3 2025, $37.9 million for Q2 2025, and $37.5 million during Q1 2025.